Indirect pathogenicity of Gram-negative bacilli in the bronchi: the value of colistin aerosol.
D000328:Adult; D000336:Aerosols; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D003091:Colistin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004417:Dyspnea / Q000139:chemically induced; D004755:Enterobacteriaceae / Q000302:isolation & purification / Q000472:pathogenicity; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011549:Pseudomonas / Q000302:isolation & purification / Q000472:pathogenicity; D011552:Pseudomonas Infections / Q000188:drug therapy*; D012138:Respiratory Therapy; D013183:Sputum / Q000382:microbiology; D012122:Ventilators, Mechanical; D014774:Virulence
D000336:Aerosols; D006634:Histamine H1 Antagonists; D007612:Kanamycin; D003091:Colistin